Medical Affairs decisions are only as good as the intelligence behind them. MedIntuit helps pharma and biotech teams monitor relevant scientific and competitive developments, interpret what they mean, and incorporate those insights into Medical Affairs strategy.

Support can range from a focused competitive landscape analysis to ongoing monitoring and intelligence reporting, depending on your therapeutic area, pipeline, and strategic priorities. Our competitive intelligence consulting is designed to help Medical Affairs leaders move from information to implications, priorities, and better-informed decisions.

Medical Affairs Competitive Intelligence

What This Service Includes

Competitive Landscape Analysis

We assess the relevant competitor, clinical, scientific, and pipeline landscape around a defined asset, therapeutic area, launch, or strategic question. The goal is not simply to catalog activity, but to identify the developments most relevant to Medical Affairs planning and decision-making..

Pipeline and Competitor Monitoring

We track relevant competitor programs, development milestones, pipeline changes, partnerships, and publicly reported activity to help your team understand how the competitive landscape is evolving.

Clinical Development Tracking

We monitor publicly available clinical development activity, including trial initiations, study design changes, enrollment updates, data readouts, and key development milestones relevant to your competitive landscape.

Scientific and Publication Landscape Analysis

We monitor relevant publications, abstracts, scientific presentations, and emerging evidence to identify evolving scientific themes, evidence gaps, and developments that may influence Medical Affairs strategy. This scientific intelligence provides context beyond pipeline activity alone and helps teams understand how the evidence landscape itself is changing..

Intelligence Synthesis and Strategic Implications

We synthesize findings into clear themes, potential implications, and priority questions for Medical Affairs rather than simply delivering a stream of updates. Reporting can be tailored for Medical Affairs leadership, Field Medical, scientific communications, cross-functional teams, or executive stakeholders.

Who this is for

  • Medical Affairs teams that need greater visibility into competitor, clinical, and scientific activity but lack the internal bandwidth for structured monitoring and synthesis

  • Pre-launch and growing pharma or biotech companies that need a clear view of the scientific and competitive landscape before key strategic milestones

  • Medical Affairs leaders who need competitive intelligence to inform launch readiness, scientific strategy, evidence planning, stakeholder engagement, or resource prioritization

  • Medical Affairs and cross-functional leaders currently relying on fragmented, ad hoc, or inconsistent competitive monitoring

  • Field Medical and scientific communications teams that need current competitive context to inform stakeholder engagement and scientific planning

  • Small to mid-sized pharma and biotech organizations seeking specialized competitive intelligence consulting without building a dedicated internal intelligence function

What You Walk Away With

Potential Deliverables

Depending on the engagement, support may include:

  • Competitive landscape analysis

  • Competitor pipeline tracker

  • Clinical development monitoring

  • Publication and evidence landscape review

  • Congress intelligence reports

  • Competitor data-readout summaries

  • Scientific intelligence briefs

  • Scientific landscape analysis

  • Recurring competitive intelligence briefs

  • Medical Affairs or executive leadership summaries

  • Competitive landscape dashboards or tracking frameworks

  • Strategic implications and priority questions

  • Ad hoc intelligence support around key milestones or competitor developments

  • Pharma competitive intelligence reports tailored to launch, pipeline, congress, or strategic planning needs

Congress and Scientific Intelligence

We track competitor data presentations, scientific themes, stakeholder activity, and emerging developments across priority medical congresses to help your team understand how the landscape is changing around key scientific milestones.

Pharma and Biotech Competitive Intelligence Support

Our pharma competitive intelligence and biotech competitive intelligence work is tailored to the scientific, clinical, and organizational questions facing each client. Engagements can focus on a single asset or competitor, a therapeutic-area landscape, a launch milestone, or a broader recurring intelligence need.

How it works

STEP 01

Define The Intelligence Questions:

We identify the competitors, programs, therapeutic areas, scientific developments, and strategic questions that matter most to your team.

STEP 02

Build the Intelligence Framework.:

We establish the sources, monitoring cadence, reporting structure, and analytical framework needed to track relevant developments consistently.

STEP 03

Analyze and Translate.:

We synthesize new information, identify meaningful patterns and changes, and translate findings into implications your Medical Affairs team can use. For senior stakeholders, reporting can be structured around the decisions, risks, opportunities, and questions requiring attention rather than the volume of information collected..

STEP 04

Refine over Time.:

For ongoing engagements, the intelligence scope evolves as competitors, pipeline milestones, and organizational priorities change..

Frequently Asked Questions

  • Both options are available. MedIntuit can conduct a focused competitive landscape analysis around a specific strategic question or milestone, or establish an ongoing monitoring and reporting process for teams that need continuous visibility.

  • Yes. Engagements can be scoped around a defined therapeutic area, competitor set, pipeline, asset, launch milestone, medical congress, or specific strategic question.

  • Competitive intelligence in pharma can help Medical Affairs leaders understand how competitor pipelines, clinical evidence, scientific narratives, congress activity, and treatment landscapes are evolving. MedIntuit focuses on interpreting those developments in the context of your Medical Affairs priorities, rather than simply reporting what changed.

  • The source mix depends on the engagement and may include publicly available clinical trial information, scientific publications, congress abstracts and presentations, company disclosures, regulatory information, pipeline updates, and other legitimate scientific and industry sources.

  • Platforms can help surface information. MedIntuit adds Medical Affairs context and interpretation, helping teams determine which developments matter, what questions they raise, and how they may affect scientific strategy, stakeholder engagement, evidence planning, or future priorities.

  • Effective pharma competitive intelligence services should do more than provide monitoring updates. They should help leaders understand which scientific, clinical, and competitor developments are material, how the landscape is changing, and what those changes may mean for Medical Affairs strategy and execution. MedIntuit structures each engagement around the client's specific strategic questions and decision needs.

  • Yes. Depending on scope, findings can be synthesized for Medical Affairs leadership, CMOs, executive teams, Field Medical leaders, scientific communications teams, or other relevant cross-functional stakeholders. The level of detail and reporting format can be adapted to the decisions each audience needs to make.

Need clearer visibility into your competitive landscape?

 Contact MedIntuit Consulting to discuss the scientific, clinical, and competitor intelligence your Medical Affairs team needs to make better-informed decisions..

Related Services

Medical Congress Strategy


Learn more →

Fractional Medical Affairs Leadership


Learn more →

Medical Affairs Architecture

Back to services →

Back to all Services

Back to services →